INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) of Class Action Lawsuit and Upcoming Deadlines

Pomerantz LLP announced a securities class action against iTonic Holdings (formerly Pheton Holdings), alleging that officers, directors, its auditor and IPO underwriters participated in a pump-and-dump scheme. The complaint alleges promoters spread baseless claims, including a fabricated Gilead Sciences acquisition rumor, before the stock collapsed roughly 95% in one session on July 29, 2025. The litigation creates substantial reputational and potential financial risk for the small-cap company, with investors eligible to seek lead-plaintiff status by September 28, 2026.

Analysis

This is principally a liquidity and market-access event for ITOC rather than a new operating-data signal. Allegations involving promotional activity, audit oversight, and IPO distribution create a durable credibility discount: prospective financings may require punitive terms, while brokers, market makers, and custodians can tighten restrictions as litigation and diligence burdens rise. In a thinly traded microcap, those frictions can matter more than eventual legal damages and can sustain extreme volatility through the September 28 lead-plaintiff deadline and any subsequent complaint amendments.

The relevant second-order readthrough is to the named IPO gatekeepers, not to GILD. A fabricated acquisition rumor does not establish a commercial, strategic, or legal exposure for GILD absent evidence of company communications or involvement; any sympathy move in GILD would be a liquidity-driven buying opportunity rather than an adverse fundamental development. For ITOC, the key bear catalyst over the next 1-3 months is independently verifiable evidence of related-party activity, abnormal insider/affiliate sales, regulatory inquiry, auditor resignation, exchange-compliance action, or a dilutive capital raise.

Consensus may overstate the informational value of a plaintiff-law-firm release: these notices are solicitation-driven, and the underlying allegations—not the announcement—determine recoverability and equity impairment. That said, the asymmetry remains unfavorable for a small issuer after a credibility break because a clean legal resolution would not by itself restore institutional sponsorship. Avoid treating a further price decline as mean reversion without verified cash, float, ownership, and listing-status data.

Key Decisions for Investors

• No new fundamental short recommendation in ITOC until borrow availability, utilization, float, and average daily dollar volume are verified; crowded hard-to-borrow microcap shorts carry materially asymmetric squeeze and recall risk.
• If ITOC remains borrowable and liquid, use a small, defined-risk 1-3 month bearish structure rather than outright size: short only against a strict buy-stop or buy put spreads where listed. Thesis is falsified by audited disclosures showing adequate cash runway, stable auditor status, and no regulatory/listing action.
• Treat any GILD weakness attributable solely to the alleged acquisition rumor as non-fundamental; maintain or add only on confirmation that GILD has no disclosed transaction, communication, or regulatory linkage. The litigation narrative should have no measurable effect on GILD revenue, pipeline value, or multiple.
• Set event alerts for SEC filings, Nasdaq deficiency notices, auditor changes, insider/Form 144 activity, and financing announcements over the next 90 days. A suspension, delisting process, or deeply discounted financing would validate the market-access bear case; absence of these developments reduces urgency to express it.